Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ramón Cacabelos. (2020) Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 673-701.
Read now
Read now
Articles from other publishers (8)
Bruno Mari Fredi, Roger Willian De Labio, Lucas Trevizani Rasmussen, Eduardo Federighi Baisi Chagas, Elizabeth Suchi Chen, Gustavo Turecki, Marilia de Arruda Cardoso Smith & Spencer Luiz Marques Payão. (2023) CDK10, CDK11, FOXO1, and FOXO3 Gene Expression in Alzheimer’s Disease Encephalic Samples. Cellular and Molecular Neurobiology.
Crossref
Crossref
Federico Emanuele Pozzi, Elisa Conti, Ildebrando Appollonio, Carlo Ferrarese & Lucio Tremolizzo. (2022) Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review. Frontiers in Neuroscience 16.
Crossref
Crossref
Caihui Wei, Shu Li, Yu Zhu, Wenzhi Chen, Cheng Li & Renshi Xu. (2022) Network pharmacology identify intersection genes of quercetin and Alzheimer’s disease as potential therapeutic targets. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Vaibhav Oli, Rohan Gupta & Pravir Kumar. (2021) FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders. Journal of Chemical Neuroanatomy 116, pages 102012.
Crossref
Crossref
Wei ZHANG, Shan-Shan BAI, Qi ZHANG, Ru-Ling SHI, He-Cheng WANG, You-Cai LIU, Tian-Jun NI, Ying WU, Zhao-Yang YAO, Yi SUN & Ming-Yong WANG. (2021) Physalin B reduces Aβ secretion through down-regulation of BACE1 expression by activating FoxO1 and inhibiting STAT3 phosphorylation. Chinese Journal of Natural Medicines 19:10, pages 732-740.
Crossref
Crossref
Wei Zhang, Shanshan Bai, Jianhua Yang, Yimin Zhang, Youcai Liu, Junjiu Nie, Dongli Meng, Ruling Shi, Zhaoyang Yao, Mingyong Wang, Hecheng Wang & Cuiping Li. (2020) FoxO1 overexpression reduces Aβ production and tau phosphorylation in vitro. Neuroscience Letters 738, pages 135322.
Crossref
Crossref
Bo-Wen Wu, Jin-Dong Guo, Mi-Shan Wu, Yu Liu, Meng Lu, Yu-Hui Zhou & Hong-Wei Han. (2020) Osteoblast-derived lipocalin-2 regulated by miRNA-96-5p/Foxo1 advances the progression of Alzheimer’s disease. Epigenomics 12:17, pages 1501-1513.
Crossref
Crossref
Md. Sahab Uddin, Anna Stachowiak, Abdullah Al Mamun, Nikolay T. Tzvetkov, Shinya Takeda, Atanas G. Atanasov, Leandro B. Bergantin, Mohamed M. Abdel-Daim & Adrian M. Stankiewicz. (2018) Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications. Frontiers in Aging Neuroscience 10.
Crossref
Crossref